Atropa belladonna root extract
RxNorm 1353220

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1353220 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Atropa belladonna root extract.

The following semantic concepts and normalized strings are associated with this clinical entity:

IN
Atropa belladonna root extract
AUI:5026979
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

IN

Ingredient (IN):
Atropa belladonna root extract
(Atom ID: 5026979)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Atropa belladonna root extract
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1353220
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
5026979
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
IN
Ingredient (A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).)
Source Code
1353220
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
UNII Crosswalk
6MW97Q6E8M - ATROPA BELLA-DONNA ROOT (INGREDIENT SUBSTANCE)
RxNorm to Unique Ingredient Identifier crosswalk.

Patient Education

Belladonna


What is it? Belladonna is a plant. The leaf and root are used to make medicine.

The name "belladonna" means "beautiful lady," and was chosen because of a risky practice in Italy. The belladonna berry juice was used historically in Italy to enlarge the pupils of women, giving them a striking appearance. This was not a good idea, because belladonna can be poisonous.

Since 2010, the FDA has been cracking down on homeopathic infant teething tablets and gels. These products may contain inaccurate doses of belladonna. Serious side effects including seizures, breathing problems, tiredness, constipation, difficulty urinating, and agitation have been reported in infants taking these products.

Though widely regarded as unsafe, belladonna is taken by mouth as a sedative, to stop bronchial spasms in asthma and whooping cough, and as a cold and hay fever remedy. It is also used for Parkinson's disease, colic, inflammatory bowel disease, motion sickness, and as a painkiller.

Belladonna is used in ointments that are applied to the skin for joint pain, pain along the sciatic nerve, and general nerve pain. Belladonna is also used in plasters (medicine-filled gauze applied to the skin) for mental disorders, inability to control muscle movements, excessive sweating, and asthma.

Belladonna is also used as suppositories for hemorrhoids.


[Learn More]


* Please review the disclaimer below.